MedPath

Nilutamide

Nilutamide Tablets

Approved
Approval ID

34ea4810-2d6c-4bd9-ae52-8bab786dee91

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 10, 2021

Manufacturers
FDA

Prasco Laboratories

DUNS: 065969375

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Nilutamide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code66993-212
Application NumberNDA020169
Product Classification
M
Marketing Category
C73605
G
Generic Name
Nilutamide
Product Specifications
Route of AdministrationORAL
Effective DateNovember 22, 2019
FDA Product Classification

INGREDIENTS (7)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
LACTOSEInactive
Code: J2B2A4N98G
Classification: IACT
DOCUSATE SODIUMInactive
Code: F05Q2T2JA0
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
NILUTAMIDEActive
Quantity: 150 mg in 1 1
Code: 51G6I8B902
Classification: ACTIB
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT

Drug Labeling Information

DESCRIPTION SECTION

LOINC: 34089-3Updated: 11/22/2019

DESCRIPTION

Nilutamide tablets contain nilutamide, a nonsteroidal, orally active antiandrogen having the chemical name 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione with the following structural formula:

nilutamide-01.jpg

Nilutamide is a microcrystalline, white to practically white powder with a molecular weight of 317.25. Its molecular formula is C12H10F3N3O4.

It is freely soluble in ethyl acetate, acetone, chloroform, ethyl alcohol, dichloromethane, and methanol. It is slightly soluble in water [<0.1% W/V at 25°C (77°F)]. It melts between 153°C and 156°C (307.4°F and 312.8°F).

Each Nilutamide tablet contains 150 mg of nilutamide. Other ingredients in Nilutamide tablets are corn starch, lactose, povidone, docusate sodium, magnesium stearate, and talc.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Nilutamide - FDA Drug Approval Details